Lv1
40 积分 2025-07-11 加入
BindingDB Entry 50010578: Discovery of 4-((2S,4S)-4-Ethoxy-1-((5-methoxy-7-methyl-1H-indol-4-yl)methyl)piperidin-2-yl)benzoic Acid (LNP023), a Factor B Inhibitor Specifically Designed To Be Applicable to Treating a Diverse Array of Complement Mediated Diseases
4个月前
已关闭
Liquid Chromatography with Hydrocarbonaceous Bonded Phases; Theory and Practice of Reversed Phase Chromatography
10个月前
已完结
IgA Nephropathy
10个月前
已完结
Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of HSK39297 in Chinese Healthy Subjects: A Phase 1 Clinical Trial
1年前
已完结
Prevalence and Trend of Biopsy-Proven IgA Nephropathy in China: A Systematic Review
1年前
已完结
Application of deuterium in research and development of drugs
1年前
已完结
Donafenib: First Approval
1年前
已完结
Deuterated active pharmaceutical ingredients: A science‐based proposal for synthesis, analysis, and control. Part 1: Framing the problem
1年前
已完结
Deuterium in drug discovery: progress, opportunities and challenges
1年前
已完结
皖公网安备34019202002308
